Ph II CHOP+Velcade in Mediastinal LBCL

Clinical trial NCT00361621 · TERMINATED

Trial details

NCT number: NCT00361621
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2006-07-01
Primary completion: 2007-11-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.